Market Cap
US$78.1b
Last Updated
2021/01/25 23:21 UTC
Data Sources
Company Financials +
Executive Summary
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. More Details
Rewards
Risk Analysis
Snowflake Analysis
Undervalued with excellent balance sheet and pays a dividend.
Similar Companies
Share Price & News
How has Anthem's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ANTM is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: ANTM's weekly volatility (5%) has been stable over the past year.
Market Performance
7 Day Return
-3.4%
ANTM
-0.7%
US Healthcare
2.6%
US Market
1 Year Return
11.1%
ANTM
18.5%
US Healthcare
26.0%
US Market
Return vs Industry: ANTM underperformed the US Healthcare industry which returned 18.5% over the past year.
Return vs Market: ANTM underperformed the US Market which returned 26% over the past year.
Shareholder returns
ANTM | Industry | Market | |
---|---|---|---|
7 Day | -3.4% | -0.7% | 2.6% |
30 Day | 2.2% | 4.7% | 5.1% |
90 Day | 5.5% | 13.6% | 17.1% |
1 Year | 12.6%11.1% | 20.0%18.5% | 28.9%26.0% |
3 Year | 27.3%22.7% | 28.4%23.0% | 46.3%36.6% |
5 Year | 160.8%143.1% | 91.7%77.6% | 126.9%101.6% |
Long-Term Price Volatility Vs. Market
How volatile is Anthem's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Does Anthem (NYSE:ANTM) Have A Healthy Balance Sheet?2 weeks ago | Simply Wall St
Are Robust Financials Driving The Recent Rally In Anthem, Inc.'s (NYSE:ANTM) Stock?4 weeks ago | Simply Wall St
Do Anthem's (NYSE:ANTM) Earnings Warrant Your Attention?Valuation
Is Anthem undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ANTM ($315.37) is trading below our estimate of fair value ($742.39)
Significantly Below Fair Value: ANTM is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ANTM is good value based on its PE Ratio (16.1x) compared to the US Healthcare industry average (30.2x).
PE vs Market: ANTM is good value based on its PE Ratio (16.1x) compared to the US market (21.3x).
Price to Earnings Growth Ratio
PEG Ratio: ANTM is poor value based on its PEG Ratio (1.2x)
Price to Book Ratio
PB vs Industry: ANTM is good value based on its PB Ratio (2.3x) compared to the US Healthcare industry average (3.6x).
Next Steps
Future Growth
How is Anthem forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?
13.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ANTM's forecast earnings growth (13.9% per year) is above the savings rate (2%).
Earnings vs Market: ANTM's earnings (13.9% per year) are forecast to grow slower than the US market (21.5% per year).
High Growth Earnings: ANTM's earnings are forecast to grow, but not significantly.
Revenue vs Market: ANTM's revenue (6.8% per year) is forecast to grow slower than the US market (10.6% per year).
High Growth Revenue: ANTM's revenue (6.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ANTM's Return on Equity is forecast to be low in 3 years time (15.4%).
Next Steps
Past Performance
How has Anthem performed over the past 5 years?
16.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ANTM has high quality earnings.
Growing Profit Margin: ANTM's current net profit margins (4.2%) are lower than last year (4.3%).
Past Earnings Growth Analysis
Earnings Trend: ANTM's earnings have grown by 16.8% per year over the past 5 years.
Accelerating Growth: ANTM's earnings growth over the past year (15.1%) is below its 5-year average (16.8% per year).
Earnings vs Industry: ANTM earnings growth over the past year (15.1%) underperformed the Healthcare industry 20.7%.
Return on Equity
High ROE: ANTM's Return on Equity (14.6%) is considered low.
Next Steps
Financial Health
How is Anthem's financial position?
Financial Position Analysis
Short Term Liabilities: ANTM's short term assets ($45.5B) exceed its short term liabilities ($28.6B).
Long Term Liabilities: ANTM's short term assets ($45.5B) exceed its long term liabilities ($24.1B).
Debt to Equity History and Analysis
Debt Level: ANTM's debt to equity ratio (64.4%) is considered high.
Reducing Debt: ANTM's debt to equity ratio has reduced from 76.5% to 64.4% over the past 5 years.
Debt Coverage: ANTM's debt is well covered by operating cash flow (37.5%).
Interest Coverage: ANTM's interest payments on its debt are well covered by EBIT (11.2x coverage).
Balance Sheet
Next Steps
Dividend
What is Anthem current dividend yield, its reliability and sustainability?
1.20%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ANTM's dividend (1.2%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.38%).
High Dividend: ANTM's dividend (1.2%) is low compared to the top 25% of dividend payers in the US market (3.85%).
Stability and Growth of Payments
Stable Dividend: ANTM's dividends per share have been stable in the past 10 years.
Growing Dividend: ANTM's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (18.6%), ANTM's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ANTM's dividends in 3 years are forecast to be thoroughly covered by earnings (13.2% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
4.8yrs
Average management tenure
CEO
Gail Boudreaux (59 yo)
3.17yrs
Tenure
US$15,473,139
Compensation
Ms. Gail Koziara Boudreaux has been President, Chief Executive Officer and Director of Anthem, Inc. since November 11, 2017. Prior to joining the Company, she served as Chief Executive Officer of GKB Globa...
CEO Compensation Analysis
Compensation vs Market: Gail's total compensation ($USD15.47M) is above average for companies of similar size in the US market ($USD10.56M).
Compensation vs Earnings: Gail's compensation has been consistent with company performance over the past year.
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 3.17yrs | US$15.47m | 0.022% $ 16.8m | |
Executive VP & CFO | 4.58yrs | US$5.11m | 0.016% $ 12.3m | |
Executive VP and Chief Administration Officer | 8yrs | US$5.25m | 0.017% $ 13.2m | |
Executive VP and President of Commercial & Specialty Business Division | 6.58yrs | US$5.08m | 0.013% $ 10.2m | |
Executive VP & President of Government Business Division | 2.58yrs | US$7.92m | 0.0014% $ 1.1m | |
SVP, Treasurer & Chief Investment Officer | 2.75yrs | no data | no data | |
Senior VP | 5.08yrs | no data | 0.0010% $ 796.8k | |
Senior VP & Chief Information Officer | 6.67yrs | no data | no data | |
Vice President of Investor Relations | 3yrs | no data | no data | |
Executive VP & Chief Legal Officer | 0.17yr | no data | no data | |
Senior Vice President of Corporate Communications | 5.75yrs | no data | no data | |
Senior VP of Commercial Business Segments & Chief Marketing Officer | 8yrs | no data | no data |
4.8yrs
Average Tenure
59.5yo
Average Age
Experienced Management: ANTM's management team is considered experienced (4.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 3.17yrs | US$15.47m | 0.022% $ 16.8m | |
Independent Director | 16.17yrs | US$376.38k | 0.0025% $ 2.0m | |
Independent Chairman of the Board | 2.67yrs | US$564.40k | no data | |
Independent Director | 16.17yrs | US$371.38k | no data | |
Independent Director | 7.5yrs | US$343.61k | no data | |
Independent Director | 6.67yrs | US$330.84k | no data | |
Independent Director | 9.5yrs | US$344.52k | 0.0020% $ 1.6m | |
Member of Advisory Board | 7.42yrs | no data | no data | |
Member of Advisory Board | 7.42yrs | no data | no data | |
Member of Advisory Board | 7.42yrs | no data | no data | |
Member of Advisory Board | 7.42yrs | no data | no data | |
Chairman of Advisory Board & National Optometric Director | 7.42yrs | no data | no data |
7.4yrs
Average Tenure
64yo
Average Age
Experienced Board: ANTM's board of directors are considered experienced (7.4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ANTM insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Anthem, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Anthem, Inc.
- Ticker: ANTM
- Exchange: NYSE
- Founded: 1944
- Industry: Managed Health Care
- Sector: Healthcare
- Market Cap: US$78.116b
- Shares outstanding: 248.70m
- Website: https://www.antheminc.com
Number of Employees
Location
- Anthem, Inc.
- 220 Virginia Avenue
- Indianapolis
- Indiana
- 46204
- United States
Listings
Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
---|---|---|---|---|---|---|
ANTM | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Oct 2001 |
A58 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Oct 2001 |
ANTM * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Oct 2001 |
0HG8 | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Oct 2001 |
A58 | ETLX (Eurotlx) | Yes | Common Stock | IT | EUR | Oct 2001 |
ANTM | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Oct 2001 |
A1NT34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 5 REPR 1 SHS UNSPON | BR | BRL | Jan 2020 |
Biography
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The ...
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2021/01/25 23:21 |
End of Day Share Price | 2021/01/25 00:00 |
Earnings | 2020/09/30 |
Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.